Nearly 50 percent of colorectal cancer survivors have continued pain interference
the ONA take:
According to a recent study published in the journal Pain Medicine, researchers from the University of Alabama at Birmingham have found that almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain interference after treatment.
For the study, researchers analyzed survey results from participants with colorectal cancer of the Cancer Care Outcomes Research and Surveillance Consortium during the initial phase of care and follow-up.
They identified 2,961 patients during the initial phase and 2,303 patients during follow-up. Results showed that at baseline, 24.7% of participants reported moderate and high pain interference compared with 23.7% during follow-up.
For 46% of participants with baseline pain interference, pain interference was either the same or worse at follow-up.
Researchers found that chemotherapy, comorbidities, depression, female gender, and radiation were associated with moderate and high pain interference at the time of diagnosis and during follow-up. On the other hand, older age was associated with improved pain interference.
The study also showed that those pulmonary disease or heart failure comorbidities had equivalent or increasing pain interference at follow-up.
Almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|